<!-- S64 — Summary of Findings: Ácido Bempedóico (AACE 2025, Table 8 — recorte original) -->
<section class="slide" data-slide-id="S64">
  <p class="label-gold" style="margin: 0 0 0.2vw 0">GRADE NA PR&Aacute;TICA &mdash; AACE 2025</p>

  <h2 style="margin: 0 0 0.15vw 0; font-size: 2.35vw">Summary of Findings: &aacute;cido bemped&oacute;ico</h2>

  <p style="margin: 0 0 0.3vw 0; font-size: 0.82vw; color: var(--muted); line-height: 1.3">
    Recorte da tabela
    <b style="color: var(--navy)">oficial</b>
    da
    <b style="color: var(--navy)">AACE 2025</b>
    (Table 8): meta-an&aacute;lise de 7 RCTs, 17&thinsp;924 pacientes. A SoF &eacute; o
    <b style="color: var(--navy)">produto final</b>
    do GRADE.
  </p>

  <!-- Image: AACE 2025 Table 8 crop -->
  <div style="flex: 1; display: flex; flex-direction: column; gap: 0.35vw">
    <div class="card" style="padding: 0; overflow: hidden; flex: 1; display: flex; flex-direction: column">
      <div class="cardHeader" style="justify-content: space-between; padding: 0.22vw 0.7vw">
        <span style="font-size: 0.56vw">RECORTE ORIGINAL &mdash; AACE 2025, TABLE 8</span>
        <span
          style="
            font-size: 0.5vw;
            padding: 0.07vw 0.3vw;
            border-radius: 0.22vw;
            background: rgba(255, 255, 255, 0.12);
            border: 1px solid rgba(255, 255, 255, 0.18);
            color: rgba(255, 255, 255, 0.8);
            font-weight: 600;
          "
        >
          Patel SB et al. &bull; Endocr Pract 2025;31:236-62
        </span>
      </div>
      <div
        class="cardBody"
        style="
          padding: 0.15vw;
          flex: 1;
          display: flex;
          align-items: start;
          justify-content: center;
          background: #fff;
          overflow: hidden;
        "
      >
        <img
          src="../assets/figures/aace_table8_crop.png"
          alt="AACE 2025 Table 8 — Summary of Findings: Bempedoic Acid Compared With Usual Care for Adults With Dyslipidemia. Meta-analysis of 7 RCTs showing outcomes for all-cause mortality, CV-related mortality, MI, stroke, coronary revascularization, discontinuation due to adverse events, and PVD events."
          style="width: 100%; height: auto; max-height: 100%; object-fit: contain; border-radius: 0.25vw"
        />
      </div>
    </div>

    <!-- Bottom: 2-part synthesis -->
    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 0.4vw">
      <div
        style="
          padding: 0.3vw 0.6vw;
          background: var(--navy);
          border-radius: var(--radius-sm);
          display: flex;
          align-items: center;
        "
      >
        <p style="font-size: 0.68vw; color: rgba(255, 255, 255, 0.92); margin: 0; line-height: 1.3">
          <strong style="color: var(--gold)">Rec. 5:</strong>
          condicional a favor (ASCVD + intoler&acirc;ncia a estatinas).
          <strong>IAM</strong>
          = &uacute;nico desfecho com redu&ccedil;&atilde;o clinicamente significativa.
        </p>
      </div>
      <div
        style="
          padding: 0.3vw 0.6vw;
          background: rgba(var(--navy-rgb), 0.06);
          border: 1px solid var(--border);
          border-radius: var(--radius-sm);
          display: flex;
          align-items: center;
        "
      >
        <p style="font-size: 0.68vw; color: var(--navy); margin: 0; line-height: 1.3">
          <strong style="color: var(--gold-dark)">Rec. 6:</strong>
          condicional
          <em>contra</em>
          uso rotineiro sem ASCVD. Mortalidade total e CV:
          <b>sem</b>
          redu&ccedil;&atilde;o significativa (RR 1,19 e 1,05).
        </p>
      </div>
    </div>
  </div>

  <div class="ref" style="margin-top: 0.1vw; font-size: 0.55vw">
    AACE 2025, Table 8 (Patel SB et al.,
    <em>Endocr Pract</em>
    2025;31:236-62).
  </div>
</section>
